So, make sure to keep an eye on PODD going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #2 (Buy). You can see the complete ...

Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 20.7% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat ...

ClearBridge Investments, an investment management firm, released its fourth-quarter 2023 “ClearBridge Aggressive Growth Strategy” investor letter, which can be ... (NASDAQ:PODD) in the fourth ...

In recent trading, shares of Insulet Corp (Symbol: PODD) have crossed above the average analyst 12-month target price of $320.60, changing hands for $321.41/share. When a stock reaches the target ...

This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for PODD? While we can never know for sure, it is pretty encouraging that estimates ...

Insulet PODD has outperformed the market over the past ... article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

Insulet (NASDAQ:PODD) has appointed Ashley McEvoy as president and chief executive officer and a member of the board of directors, effective immediately. McEvoy succeeds Jim Hollingshead ...

So, make sure to keep an eye on PODD going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #2 (Buy). You can see the complete ...